BSC
EW icon

BOLTON SECURITIES CORPORATION’s Edwards Lifesciences EW Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
+13,580
New +$1.12M 0.05% 353
2025
Q3 		$1.2M Buy
+15,385
New +$1.2M 0.06% 334
2025
Q1 		$1.15M Buy
+15,879
New +$1.14M 0.07% 310

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's EW Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Edwards Lifesciences (EW) in Q1 2026: 13,580 shares worth $1.09M. The stake represents 0.05% of the portfolio and ranks #353 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in EW as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in EW in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.2M in Q3 2025. 1,297 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 13,580 shares of Edwards Lifesciences worth $1.09M as of Q1 2026.
  • Edwards Lifesciences was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Edwards Lifesciences made up 0.05% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #353 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Edwards Lifesciences position peaked at $1.2M in Q3 2025.
  • 1,297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.